Saad, F. (2016) “Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone”, Canadian Urological Association Journal, 10(3-4), pp. 102–9. doi: 10.5489/cuaj.3470.